Antibiotic therapy for pelvic inflammatory disease
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pelvic inflammatory disease (PID) is an infection that affects 4% to 12% of young women, and is one of the most common causes of morbidity in this age group. The main intervention for acute PID is the use of broad-spectrum antibiotics which cover Chlamydia trachomatis, Neisseria gonorrhoeae, and anaerobic bacteria, administered intravenously, intramuscularly, or orally. In this review, we assessed the optimal treatment regimen for PID. OBJECTIVES: To assess the effectiveness and safety of antibiotic regimens used to treat pelvic inflammatory disease. SEARCH METHODS: We searched the Cochrane Sexually Transmitted Infections Review Group's Specialized Register, which included randomized controlled trials (RCTs) from 1944 to 2016, located through electronic searching and handsearching; the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid platform (1991 to July 2016); MEDLINE (1946 to July 2016); Embase (1947 to July 2016); LILACS, iAHx interface (1982 to July 2016); World Health Organization International Clinical Trials Registry Platform (July 2016); Web of Science (2001 to July 2016); OpenGrey (1990, 1992, 1995, 1996, and 1997); and abstracts in selected publications. SELECTION CRITERIA: We included RCTs comparing the use of antibiotics with placebo or other antibiotics for the treatment of PID in women of reproductive age, either as inpatient or outpatient treatment. We limited our review to comparison of drugs in current use that are recommended for consideration by the 2015 US Centers for Disease Control and Prevention (CDC) guidelines for treatment of PID. DATA COLLECTION AND ANALYSIS: At least two review authors independently selected trials for inclusion, extracted data, and assessed risk of bias. We contacted investigators to obtain missing information. We resolved disagreements by consensus or by consulting a fourth review author if necessary. We assessed the quality of the evidence using GRADE criteria, classifying it as high, moderate, low, or very low. We calculated Mantel-Haenszel risk ratios (RR), using either random-effects or fixed-effect models and number needed to treat for an additional beneficial outcome or for an additional harmful outcome, with their 95% confidence interval (CI), to measure the effect of the treatments. We conducted sensitivity analyses limited to studies at low risk of bias, for comparisons where such studies were available. MAIN RESULTS: = 0%, very low-quality evidence). AUTHORS' CONCLUSIONS: We found no conclusive evidence that one regimen of antibiotics was safer or more effective than any other for the cure of PID, and there was no clear evidence for the use of nitroimidazoles (metronidazole) compared to use of other drugs with activity over anaerobes. Moderate-quality evidence from a single study at low risk of bias suggested that a macrolide (azithromycin) may be more effective than a tetracycline (doxycycline) for curing mild-moderate PID. Our review considered only the drugs that are currently used and mentioned by the CDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Confidence intervals for the number needed to treat.
Altman, D. G. (1998) · BMJ · doi:10.1136/bmj.317.7168.1309 · Cited by 938
How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?
Fewtrell, M. S., Kennedy, K., Singhal, A., Martin, R. M., Ness, A., Hadders-Algra, M., Koletzko, B., & Lucas, A. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.127316 · Cited by 601
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
Sterne, J. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000076 · Cited by 60
Research works printed but not linked: 168
- Apuzzio, 1989, Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection, American Journal of Medicine, 87, 148S, 10.1016/0002-9343(89)90046-6 · DOI
- Arredondo, 1997, Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients, Clinical Infectious Diseases, 24, 170, 10.1093/clinids/24.2.170 · DOI
- Aşicioğlu, 2013, Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial, European Journal of Obstetrics and Gynecology and Reproductive Biology, 171, 116, 10.1016/j.ejogrb.2013.08.012 · DOI
- Balbi, 1996, Acute pelvic inflammatory disease: comparison of therapeutic protocols, Minerva Ginecologica, 48, 19
- Bevan, 2003, Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease, Journal of International Medical Research, 31, 45, 10.1177/147323000303100108 · DOI
- Buisson, 1989, Treatment of upper genital infections in women. Multicenter study of the comparative efficacy and tolerance of an amoxicillin-clavulanic acid combination and of a triple antibiotic combination, Revue Française de Gynecologie et d'Obstetrique, 84, 699
- Burchell, 1987, Efficacy of different antibiotics in the treatment of pelvic inflammatory disease, South African Medical Journal, 72, 248
- Ciraru-Vigneron, 1986, The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections, Pathologie Biologie, 34, 665
- Ciraru-Vigneron, 1989, Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease, Pharmatherapeutica, 5, 312
- Crombleholme, 1986, Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections, Drugs, 31, 11, 10.2165/00003495-198600312-00003 · DOI
- Crombleholme, 1987, Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections, American Journal of Obstetrics and Gynaecology, 156, 507, 10.1016/0002-9378(87)90321-8 · DOI
- Crombleholme, 1989, Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin, American Journal of Medicine, 87, 142S, 10.1016/0002-9343(89)90045-4 · DOI
- Fischbach, 1994, Ciprofloxacin/metronidazol vs. cefoxitin/doxycyclin: vergleich zweier therapieschemata zur behandlung der akuten pelvinen infektion, Geburtshilfe und Frauenheilkunde, 54, 337, 10.1055/s-2007-1022851 · DOI
- Giraud, 1989, A comparison of the efficacy of and tolerance to Augmentin used alone and as one of three drugs used to treat acute upper genital tract infections. Results of a multicentre trial 152 cases, Contraception Fertilite Sexualite, 17, 941
- Heinonen, 1989, A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease, Scandinavian Journal of Infectious Diseases Supplement, 60, 66
- Hemsell, 1994, Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease, Clinical Infectious Diseases, 19, 720, 10.1093/clinids/19.4.720 · DOI
- Heystek, 2009, A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease, International Journal of STD & AIDS, 20, 690, 10.1258/ijsa.2008.008495 · DOI
- Hoyme, 1993, Quinolones in the treatment of uncomplicated salpingitis: ofloxacin/metronidazole vs gentamicin/clindamycin. Infections in the Gynecology and obstetrics., Infektionen in der Gynäcologie und geburtshilfe, VII.8a, 607
- Judlin, 2010, Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study, BJOG, 117, 1475, 10.1111/j.1471-0528.2010.02687.x · DOI
- Landers, 1991, Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease, American Journal of Obstetrics and Gynecology, 164, 849, 10.1016/0002-9378(91)90528-Y · DOI
- Leboeuf, 1987, Prospective randomized trial comparing the efficacy and the tolerance of clindamycin-gentamicin versus metronidazole-gentamicin in acute utero-adnexal infections in hospitalized patients, Revue Française de Gynecologie et d'Obstetrique, 82, 9
- Malhotra, 2003, Ciprofloxacin-tinidazole combination, fluconazole-azithromycin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial, Indian Journal of Medical Sciences, 57, 549
- Maria, 1992, Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial, Acta Obstetricia et Gynecologica Scandinavica, 71, 129, 10.3109/00016349209007970 · DOI
- Martens, 1990, Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease, Journal of Antimicrobial Chemotherapy, 26, 37, 10.1093/jac/26.suppl_A.37 · DOI
- Martens, 1993, Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease, Southern Medical Journal, 86, 604, 10.1097/00007611-199306000-00002 · DOI
- Okada, 1988, Comparative clinical study on ciprofloxacin and cefroxadine in the treatment of infections in obstetrics and gynecology [in Japanese], Chemotherapy, 36, 821
- Ross, 2006, Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial, Sexually Transmitted Infections, 82, 446, 10.1136/sti.2005.019109 · DOI
- Roy, 1985, Cefotaxime in the treatment of female pelvic soft tissue infections, Infection, 13, S56, 10.1007/BF01644220 · DOI
- Roy, 1990, A comparison of the efficacy and safety of ceftizoxime with doxycycline versus conventional CDC therapies in the treatment of upper genital tract infection with or without a mass, Clinical Therapeutics, 12, 53
- Savaris, 2007, Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial, Obstetrics and Gynecology, 110, 53, 10.1097/01.AOG.0000268801.90261.27 · DOI
- Sirayapiwat, 2002, Triple therapies versus clindamycin plus gentamicin in the treatment of acute pelvic inflammatory disease: a randomized controlled trial, Thai Journal of Obstetrics and Gynaecology, 14, 215
- Soper, 1988, A comparison of two antibiotic regiments for treatment of pelvic inflammatory disease, Obstetrics and Gynecology, 72, 7
- Sweet, 1985, Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections, American Journal of Obstetrics and Gynecology, 152, 808, 10.1016/S0002-9378(85)80068-5 · DOI
- Thadepalli, 1991, Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin, Obstetrics and Gynaecology, 78, 696
- Tison, 1988, Treatment of acute non-chlamydial salpingitis. Study of the efficacy and tolerance of a single-therapy antibiotic: Augmentin, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 17, 513
- Walters, 1990, A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease, Obstetrics and Gynecology, 75, 867
- Wendel, 1991, A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis, American Journal of Obstetrics and Gynecology, 164, 1390, 10.1016/0002-9378(91)91479-G · DOI
- Acar, 1989, Piperacillin alone vs triple antibiotic combination in gynecological infections, Journal of chemotherapy, 1, 403, 10.1080/1120009X.1989.11738933 · DOI
- Andersson, 1980, A comparison of two different dosages of pivampicillin and doxycycline in patients with gynaecological infections, Current Medical Research and Opinion, 6, 513, 10.1185/03007998009109479 · DOI
- Bartlett, 1982, Therapeutic trial of moxalactam in intra-abdominal sepsis and gynaecological infections, Drugs under Experimental and Clinical Research, VIII, 483
- Berkeley, 1986, Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections, Surgery, Gynecology & Obstetrics, 162, 204
- Blanco, 1983, Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections, Antimicrobial Agents and Chemotherapy, 24, 500, 10.1128/AAC.24.4.500 · DOI
- Brihmer, 1988, Second look laparoscopy after treatment of acute salpingitis with doxycycline/benzylpenicillin procaine or trimethoprim-sulfamethoxazole, Scandinavian Journal of Infectious Diseases, 53, 63
- Brihmer, 1989, Second look laparoscopy; evaluation of two different antibiotic regimens after treatment of acute salpingitis, European Journal of Obstetrics & Gynecology, 30, 263, 10.1016/0028-2243(89)90011-7 · DOI
- Bruhat, 1986, Treatment of acute salpingitis with sulbactam/ampicillin, Drugs, 31 Suppl, 7, 10.2165/00003495-198600312-00002 · DOI
- Bruhat, 1989, Treatment of acute salpingitis with sulbactam/ampicillin, International Journal of Gynecology & Obstetrics, 31 Suppl, 41, 10.1016/0020-7292(89)90091-X · DOI
- Bruno, 1985, A clinical trial with the new antibiotic combination piperacillin/flucloxacillin used on gynaecological postoperative infections, Current Therapeutic Research, 38, 465
- Carty, 1973, The use of oxyphenbutazone ('Tanderil') in acute pelvic inflammatory disease, Current Medical Research and Opinion, 1, 203, 10.1185/03007997309111668 · DOI
- Chatwani, 1997, Trospectomycin in acute pelvic inflammatory disease: a preliminary report, Infectious Diseases in Obstetrics and Gynecology, 5, 215, 10.1002/(SICI)1098-0997(1997)5:3<215::AID-IDOG4>3.0.CO;2-O · DOI
- Confino, 1988, Mezlocillin versus doxycycline in the treatment of acute salpingitis, Mount Sinai Journal of Medicine, 55, 154
- Beer, 1983, Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. A comparative study, South African Medical Journal, 64, 733
- Drasa, 2010, Azithromycin vs. clarithromycin and both combination in treatment of mycoplasma genitalium, European Urology Supplements, 9, 172, 10.1016/S1569-9056(10)60483-6 · DOI
- Drusano, 1982, A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections, Surgery, Gynecology & Obstetrics, 154, 715
- Duarte, 1995, Evaluation of doxycycline for the complementary treatment of acute inflammatory pelvic disease. A double-blind study, Revista Brasileira de Medicina do Esporte, 52, 651
- Faro, 1988, Ceftizoxime versus cefotaxime in the treatment of hospitalized patients with pelvic inflammatory disease, Current Therapeutic Research, 43, 349
- Fedele, 1989, Treatment of Chlamydia trachomatis endometritis with josamycin, Journal of Chemotherapy, 1, 911
- Frongillo, 1992, Imipenem versus netilmicin plus chloramphenicol in gynecological upper tract infections: a comparative study, Chemotherapy, 5, 41
- Gall, 1981, Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections, Obstetrics & Gynecology, 57, 51
- Gall, 1990, Therapeutic dilemmas in the treatment of pelvic infections, Journal of Reproductive Medicine, 35, 1091
- Gall, 1990, Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease, Obstetrics & Gynecology, 75, 282
- Gerber, 1992, Treatment of acute salpingitis with tetracycline/metronidazole with or without additional balneotherapy. Augmentan or ciprofloxacin/metronidazole: a second-look-laparoscopy study, Geburtshilfe und Frauenheilkunde, 52, 165, 10.1055/s-2007-1026119 · DOI
- Gerstner, 1990, Comparison of ceftriaxone (1 x 1 g/day) versus cefotaxime (3 x 1 g/day) for gynecologic and obstetric infections. A randomized clinical trial, Gynecologic and Obstetric Investigation, 29, 273, 10.1159/000293333 · DOI
- Ghomian, 2012, Comparing ceftriaxone plus azithromycin or doxycycline for outpatient treatment in pelvic inflammatory disease, Iranian Journal of Obstetrics, Gynecology and Infertility, 14, 1
- Giamarellou, 1982, Ornidazole versus clindamycin: Comparative evaluation in the treatment of 140 serious anaerobic infections, Chemotherapy, 28, 502, 10.1159/000238140 · DOI
- Gibbs, 1980, A trial of spectinomycin hydrochloride compared with aqueous penicillin G plus kanamycin for treatment of severe pelvic inflammatory disease, Sexually Transmitted Diseases, 7, 21, 10.1097/00007435-198001000-00006 · DOI
- Gjonnaess, 1981, Treatment of pelvic inflammatory disease. Effects of lymecycline and clindamycin, Current Therapeutic Research, 29, 885
- Grafford, 1980, Bacampicillin in the treatment of pelvic inflammatory disease: a study of two dosage regimens, Infection, 8, 290, 10.1007/BF01640921 · DOI
- Grafford, 1981, Twice daily dosage of bacampicillin: a summary of clinical documentation, Journal of Antimicrobial Chemotherapy, 8, 119, 10.1093/jac/8.suppl_C.119 · DOI
- Gunning, 1986, A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections, Surgery, Gynecology & Obstetrics, 163, 156
- Gunning, 1986, A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease, Drugs, 31, 14, 10.2165/00003495-198600312-00004 · DOI
- Hager, 1989, Efficacy of oral antibiotics following parenteral antibiotics for serious infections in obstetrics and gynecology, Obstetrics & Gynecology, 73, 326
- Harding, 1982, A preliminary report on the use of ceftizoxime versus clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections, Journal of Antimicrobial Chemotherapy, 10, 191, 10.1093/jac/10.suppl_C.191 · DOI
- Harding, 1984, Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections, Reviews of Infectious Diseases, 6, S283, 10.1093/clinids/6.Supplement_1.S283 · DOI
- Hemsell, 1982, Clinical experience with cefotaxime in obstetric and gynecologic infections, Reviews of Infectious Diseases, 4, S432, 10.1093/clinids/4.Supplement_2.S432 · DOI
- Hemsell, 1987, Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess, Surgery, Gynecology & Obstetrics, 165, 223
- Hemsell, 1988, Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease, Drugs, 35, 39, 10.2165/00003495-198800357-00010 · DOI
- Hemsell, 1988, Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections, American Journal of Obstetrics & Gynecology, 158, 722, 10.1016/S0002-9378(16)44535-7 · DOI
- Hemsell, 1988, Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease. Microbial susceptibility and clinical response to four therapeutic regimens, Journal of Reproductive Medicine, 33, 799
- Hemsell, 1988, Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease, Drugs, 35, 39, 10.2165/00003495-198800357-00010 · DOI
- Hemsell, 1990, Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin, Journal of International Medical Research, 18, 85D
- Hemsell, 1991, Comparative bacteriology of parenteral single-agent vs. combination therapy in salpingitis, Advances in Therapy, 8, 27
- Hemsell, 1993, Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin/sulbactam vs. cefoxitin, Infectious Diseases in Obstetrics and Gynecology, 1, 123, 10.1155/S1064744993000286 · DOI
- Hemsell, 1997, A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women, Clinical Infectious Diseases, 24, S222, 10.1093/clinids/24.Supplement_2.S222 · DOI
- Henry, 1985, Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections, Reviews of Infectious Diseases, 7, S703, 10.1093/clinids/7.Supplement_4.S703 · DOI
- Holloway, 1988, Infection in women. Clinical experience with beta-lactamase inhibitors, Journal of Reproductive Medicine, 33, 595
- Ibrahim, 1990, Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease, Renal Failure, 12, 199, 10.3109/08860229009065564 · DOI
- Jemsek, 1997, Ampicillin/sulbactam vs. cefoxitin for the treatment of pelvic inflammatory disease, Infectious Diseases in Obstetrics and Gynecology, 5, 319, 10.1002/(SICI)1098-0997(1997)5:5<319::AID-IDOG3>3.0.CO;2-Q · DOI
- Jordheim, 1974, Pivampicillin treatment of urogenital infections in gynaecological patients. Clinical evaluation, Infection, 2, 142, 10.1007/BF01642234 · DOI
- Judlin, 1995, Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, 24, 253
- Knuppel, 1988, Cefotetan: comparative and non comparative studies in obstetric and gynecologic infections, Southern Medical Journal, 81, 185, 10.1097/00007611-198802000-00010 · DOI
- Kosseim, 1991, Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam, Antimicrobial Agents and Chemotherapy, 35, 1651, 10.1128/AAC.35.8.1651 · DOI
- Kotoulas, 1992, Comparison of ceftriaxone plus ornidazole, ceftazidime plus ornidazole, and ornidazole in the treatment of pelvic inflammatory disease (PID), Chemotherapy, 5, 159
- Kunzig, 1990, Sequential therapy with ciprofloxacin i.v./p.o. and metronidazole compared with cefotiam and metronidazole in the treatment of gynecological infections, Chemotherapy, 3, 225
- Kvile, 1980, Treatment of salpingitis with pivampicillin. A comparison of twice-daily and thrice-daily dosages, Infection, 8, 32, 10.1007/BF01677396 · DOI
- Larsen, 1986, Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections, Clinical Therapeutics, 9, 77
- Larsen, 1992, Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections, Clinical Therapeutics, 14, 90
- Livengood, 1992, Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease, American Journal of Obstetrics and Gynecology, 166, 519, 10.1016/0002-9378(92)91661-S · DOI
- Ma, 2010, Multicenter randomized controlled clinical study on levornidazole and sodium chloride injection in the treatment of pelvic anaerobic infections [in Chinese], Chinese Journal of Obstetrics & Gynecology, 45, 754
- Maggioni, 1998, Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin, Journal of Chemotherapy, 10, 114, 10.1179/joc.1998.10.2.114 · DOI
- Maki, 1979, A comparative clinical trial of sisomicin and gentamicin in major gram-negative infections, Infection, 7, S298, 10.1007/BF01646260 · DOI
- Mandell, 1993, A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infections, Canadian Journal of Infectious Diseases, 4, 279, 10.1155/1993/567478 · DOI
- Marier, 1982, Piperacillin v carbenicillin in the therapy for serious infections, Archives of Internal Medicine, 142, 2000, 10.1001/archinte.1982.00340240022005 · DOI
- Marshall, 1982, Effectiveness of mezlocillin in female genital tract infections, Journal of Antimicrobial Chemotherapy, 9, 149, 10.1093/jac/9.suppl_A.149 · DOI
- Matsuda, 1988, Comparative clinical study of CS-807 (cefpodoxime proxetil) and bacampicillin (BAPC) on the infectious disease in the field of obstetrics and gynecology [in Japanese], Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines), 4, 1641
- Matsuda, 1989, Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections [in Japanese], Chemotherapy, 37, 667
- Moghtadaei, 2008, Comparison of ceftriaxone plus weekly azithromycin or daily ofloxacin for outpatient treatment of pelvic inflammatory disease: a randomized clinical trial, Journal of Family and Reproductive Health, 2, 87
- Moghtadaei, 2008, Comparison of ceftriaxone plus weekly azithromycin or daily ofloxacin for outpatient treatment of pelvic inflammatory disease: a randomized clinical trial, Journal of Family and Reproductive Health, 2, 87
- Ness, 2002, Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial, American Journal of Obstetric and Gynecology, 186, 929, 10.1067/mob.2002.121625 · DOI · Paper page
- Ness, 2005, Effectiveness of treatment strategies of some women with pelvic inflammatory disease a randomized trial, Obstetrics and Gynaecology, 106, 573, 10.1097/01.AOG.0000175193.37531.6e · DOI
- Nicolle, 1986, Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections, Archives of Surgery, 121, 891, 10.1001/archsurg.1986.01400080033005 · DOI
- Paavonen, 1985, Factors predicting abnormal hysterosalpingographic findings in patients treated for acute pelvic inflammatory disease, International Journal of Gynaecology and Obstetrics, 23, 171, 10.1016/0020-7292(85)90100-6 · DOI
- Pastorek, 1985, Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection, American Journal of Medicine, 29, 161, 10.1016/0002-9343(85)90151-2 · DOI
- Roy, 1998, Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group, American Journal of Surgery, 178, 67S, 10.1016/S0002-9610(98)00223-2 · DOI
- Ruiz Conde, 1999, Comparative multicenter study between meropenem versus clindamycin with gentamicin for the treatment of inpatient with obstetrics and/or gynecologic infections, Clínica e Investigación en Ginecología y Obstetricia, 26, 202
- Sanfilippo, 1989, Mezlocillin versus penicillin and tobramycin in adolescent pelvic inflammatory disease: a prospective study, Internal Pediatrics, 4, 53
- Schnider, 1979, A comparison of netilmicin and gentamicin in the treatment of pelvic infections, Obstetrics & Gynecology, 54, 554
- Senft, 1986, Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections, Drugs, 31, 18, 10.2165/00003495-198600312-00005 · DOI
- Sesti, 1990, Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin, La Clinica Terapeutica, 132, 41
- Sharma, 2007, Comparison of ofloxacin and ornidazole with probiotic versus doxycycline and metronidazole for the outpatient treatment of pelvic inflammatory disease, JK Science, 9, 66
- Silva, 1990, Imipenen/cilastatin in the treatment of pelvic infections, Revista Brasileira de Medicina, 47, 196
- Skerk, 2003, Comparative study of intravenous azithromycin alone or intravenous and oral azithromycin for the treatment of pelvic inflammatory disease caused by Chlamydia trachomatis [in Croatian], Croatian Journal of Infection, 23, 125
- Spence, 1981, Randomized prospective comparison of ampicillin and doxycycline in the treatment of acute pelvic inflammatory disease in hospitalized patients, Sexually Transmitted Diseases, 8, 164, 10.1097/00007435-198104000-00026 · DOI
- Stamm, 1984, Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis, New England Journal of Medicine, 310, 545, 10.1056/NEJM198403013100901 · DOI · Paper page
- Stiglmayer, 1996, Sulbactam/ampicillin versus cefoxitin in the treatment of gynaecological infection: an antibiotic therapeutic study, International Journal of Antimicrobial Agents, 6, 61, 10.1016/0924-8579(95)00055-0 · DOI
- Sweet, 1988, Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline, American Journal of Obstetrics and Gynecology, 158, 736, 10.1016/S0002-9378(16)44537-0 · DOI
- Sweet, 1994, Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection, Obstetrics & Gynecology, 83, 280
- Takase, 1986, Comparative clinical study of ofloxacin (OFLX) and amoxicillin (AMPC) of the infectious disease in the field of obstetrics and gynecology [in Japanese], Chemotherapy, 34, 31
- Tellado, 2002, Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections, Surgical Infection Society, 3, 303, 10.1089/109629602762539535 · DOI
- Tellado, 2002, Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections, Surgical Infection Society, 3, 303, 10.1089/109629602762539535 · DOI
- Teppler, 2002, Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam, Surgical Infection Society, 3, 337, 10.1089/109629602762539553 · DOI
- Thompson, 1980, The microbiology and therapy of acute pelvic inflammatory disease, American Journal of Obstetrics and Gynecology, 136, 179, 10.1016/0002-9378(80)90592-X · DOI
- Thompson, 1985, High failure rates in outpatient treatment of salpingitis with either tetracycline alone or penicillin/ampicillin combination, American Journal of Obstetrics and Gynecology, 152, 635, 10.1016/S0002-9378(85)80036-3 · DOI
- Tulkens, 1988, Safety and efficacy of aminoglycosides once-a-day: experimental data and randomized controlled evaluation in patients suffering from pelvic inflammatory disease, Journal of Drug Development, 1, 71
- Tulkens, 1991, Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin, Journal of Antimicrobial Chemotherapy, 27, 49, 10.1093/jac/27.suppl_C.49 · DOI
- Gelderen, 1987, A comparative trial of ceftriaxone and a penicillin/chloramphenicol combination in gynaecological infections complicated by peritonitis, South African Medical Journal, Suppl 2, 13
- Walker, 1991, Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis, Sexually Transmitted Diseases, 18, 119, 10.1097/00007435-199118020-00012 · DOI
- Wikler, 1989, Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID), Journal of Chemotherapy, 1, 882
- Witte, 1993, A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease, European Journal of Obstetrics, Gynecology and Reproductive Biology, 50, 153, 10.1016/0028-2243(93)90180-K · DOI
- Wynd, 1999, Cost-effectiveness of ampicillin/sulbactam versus cefoxitin in the treatment of pelvic inflammatory disease, Journal of Infectious Disease Pharmacotherapy, 4, 35, 10.1300/J100v04n01_06 · DOI
- Aghaizu, 2011, What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial, Sexually Transmitted Infections, 87, 312, 10.1136/sti.2010.048694 · DOI
- Baveja, 2001, A study of bacterial pathogens in acute pelvic inflammatory disease, Journal of Communicable Diseases, 88, 121
- Blanchard, 1998, The evolving epidemiology of chlamydial and gonococcal infections in response to control programs in Winnipeg, Canada, American Journal of Public Health, 88, 1496, 10.2105/AJPH.88.10.1496 · DOI
- Datta, 2012, Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008, Sexually Transmitted Diseases, 39, 92, 10.1097/OLQ.0b013e31823e2ff7 · DOI
- DeWitt, 2010, Tuboovarian abscess: is size associated with duration of hospitalization and complications?, Obstetrics and Gynecology International, 2010, 1, 10.1155/2010/847041 · DOI
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test., BMJ, 315, 634
- Eschenbach, 1975, Polymicrobial etiology of acute pelvic inflammatory disease, New England Journal of Medicine, 293, 166, 10.1056/NEJM197507242930403 · DOI · Paper page
- Hager, 1983, Criteria for diagnosis and grading of salpingitis [editorial]., Obstet Gynecol, 61, 113
- Haggerty, 2006, Epidemiology, pathogenesis and treatment of pelvic inflammatory disease, Expert Review of Anti-infective Therapy, 4, 235, 10.1586/14787210.4.2.235 · DOI
- Judlin, 2010, Current concepts in managing pelvic inflammatory disease, Current Opinion in Infectious Diseases, 23, 83, 10.1097/QCO.0b013e328334de21 · DOI
- Mahafzah, 2008, Prevalence of sexually transmitted infections among sexually active Jordanian females, Sexually Transmitted Diseases, 35, 607, 10.1097/OLQ.0b013e3181676bbd · DOI
- McCormack, 1977, Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride, Sexually Transmitted Diseases, 4, 125, 10.1097/00007435-197710000-00001 · DOI · Paper page
- Molander, 2003, Observer agreement with laparoscopic diagnosis of pelvic inflammatory disease using photographs, Obstetrics and Gynecology, 101, 875
- Morris, 2014, A cross-sectional study showing differences in the clinical diagnosis of pelvic inflammatory disease according to the experience of clinicians: implications for training and audit, Sexually Transmitted Infections, 90, 445, 10.1136/sextrans-2014-051646 · DOI
- Ness, 2006, Prediction of pelvic inflammatory disease among young, single, sexually active women, Sexually Transmitted Diseases, 33, 137, 10.1097/01.olq.0000187205.67390.d1 · DOI
- Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, 10, e0143304, 10.1371/journal.pone.0143304 · DOI · Paper page
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
- Ross, 2004, What is endometritis and does it require treatment?, Sexually Transmitted Infections, 80, 252, 10.1136/sti.2004.009548 · DOI
- Ross, 2007, European guidelines of the management of pelvic inflammatory disease, International Journal of STD and AIDS, 18, 662, 10.1258/095646207782193911 · DOI
- Ross, 2014, 2012 European guideline for the management of pelvic inflammatory disease, International Journal of STD & AIDS, 25, 1, 10.1177/0956462413498714 · DOI
- Ross, 2014, Pelvic inflammatory disease, American Family Physician, 90, 725
- Simms, 1999, The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales, International Journal of STD and AIDS, 10, 448, 10.1258/0956462991914447 · DOI
- Soper, 1991, Diagnosis and laparoscopic grading of acute salpingitis., Am J Obstet Gynecol, 164, 1370, 10.1016/0002-9378(91)91474-B · DOI
- Soper, 2010, Pelvic inflammatory disease, Obstetrics and Gynecology, 116, 419, 10.1097/AOG.0b013e3181e92c54 · DOI · Paper page
- Sutton, 2008, Recent developments in meta-analysis, Statistics in Medicine, 27, 625, 10.1002/sim.2934 · DOI · Paper page
- Trent, 2011, Estimating the direct costs of pelvic inflammatory disease in adolescents: a within-system analysis, Sexually Transmitted Diseases, 38, 326, 10.1097/OLQ.0b013e3181fc6c65 · DOI
- Walker, 1993, Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy, Journal of Infectious Diseases, 168, 969, 10.1093/infdis/168.4.969 · DOI
- Walker, 2007, Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines, Clinical Infectious Diseases, 28 (Suppl 1), S29
- Workowski, 2015, Sexually transmitted diseases treatment guidelines, 2015, MMWR Recommendations and Reports, 64, 1
Cited by
Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., & Meng, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110985 · Cited by 720
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
Antibiotic therapy for pelvic inflammatory disease
Savaris, R. F., Fuhrich, D. G., Maissiat, J., Duarte, R. V., & Ross, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010285.pub3 · Cited by 81
Self-citation
Metadata
- Authors
- Savaris, R. F., Fuhrich, D. G., Duarte, R. V., Franik, S., & Ross, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-04-24
- Volume
- 4
- Pages
- CD010285-CD010285
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2409869916
- Cited by
- 67
- References
- 3
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Update notices
- new_version (2020-08-20)
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.